The global eHealth market size is accounted at USD 484.83 billion in 2025 and is forecasted to hit around USD 2,186.78 billion by 2034, representing a CAGR of 18.22% from 2025 to 2034. The North America market size was estimated at USD 159.94 billion in 2024 and is expanding at a CAGR of 18.37% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: EHealth Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. EHealth Market, by Product Type
8.1.1. ePrescribing
8.1.1.1. Market Revenue and Forecast
8.1.2. EHR
8.1.2.1. Market Revenue and Forecast
8.1.3. Telemedicine
8.1.3.1. Market Revenue and Forecast
8.1.4. mHealth
8.1.4.1. Market Revenue and Forecast
8.1.5. Health Management
8.1.5.1. Market Revenue and Forecast
8.1.6. Clinical Decision Support
8.1.6.1. Market Revenue and Forecast
8.1.7. Information System
8.1.7.1. Market Revenue and Forecast
8.1.8. Radiology Information Systems
8.1.8.1. Market Revenue and Forecast
8.1.9. Laboratory Information Systems
8.1.9.1. Market Revenue and Forecast
8.1.10. Cardiovascular Information Systems
8.1.10.1. Market Revenue and Forecast
8.1.11. Others
8.1.11.1. Market Revenue and Forecast
9.1. EHealth Market, by Service
9.1.1. Diagnostic
9.1.1.1. Market Revenue and Forecast
9.1.2. Monitoring
9.1.2.1. Market Revenue and Forecast
9.1.3. Healthcare Strengthening
9.1.3.1. Market Revenue and Forecast
9.1.4. Treatment
9.1.4.1. Market Revenue and Forecast
9.1.5. Database Management
9.1.5.1. Market Revenue and Forecast
10.1. EHealth Market, by End Use Type
10.1.1. Healthcare Providers
10.1.1.1. Market Revenue and Forecast
10.1.2. Insurers
10.1.2.1. Market Revenue and Forecast
10.1.3. Healthcare Consumers
10.1.3.1. Market Revenue and Forecast
10.1.4. Government
10.1.4.1. Market Revenue and Forecast
11.1. EHealth Market, by Deployment Type
11.1.1. On-premise
11.1.1.1. Market Revenue and Forecast
11.1.2. Cloud-based
11.1.2.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product
12.1.2. Market Revenue and Forecast, by Service
12.1.3. Market Revenue and Forecast, by End Use Type
12.1.4. Market Revenue and Forecast, by Deployment Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product
12.1.5.2. Market Revenue and Forecast, by Service
12.1.5.3. Market Revenue and Forecast, by End Use Type
12.1.5.4. Market Revenue and Forecast, by Deployment Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product
12.1.6.2. Market Revenue and Forecast, by Service
12.1.6.3. Market Revenue and Forecast, by End Use Type
12.1.6.4. Market Revenue and Forecast, by Deployment Type
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product
12.2.2. Market Revenue and Forecast, by Service
12.2.3. Market Revenue and Forecast, by End Use Type
12.2.4. Market Revenue and Forecast, by Deployment Type
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product
12.2.5.2. Market Revenue and Forecast, by Service
12.2.5.3. Market Revenue and Forecast, by End Use Type
12.2.5.4. Market Revenue and Forecast, by Deployment Type
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product
12.2.6.2. Market Revenue and Forecast, by Service
12.2.6.3. Market Revenue and Forecast, by End Use Type
12.2.6.4. Market Revenue and Forecast, by Deployment Type
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product
12.2.7.2. Market Revenue and Forecast, by Service
12.2.7.3. Market Revenue and Forecast, by End Use Type
12.2.7.4. Market Revenue and Forecast, by Deployment Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product
12.2.8.2. Market Revenue and Forecast, by Service
12.2.8.3. Market Revenue and Forecast, by End Use Type
12.2.8.4. Market Revenue and Forecast, by Deployment Type
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product
12.3.2. Market Revenue and Forecast, by Service
12.3.3. Market Revenue and Forecast, by End Use Type
12.3.4. Market Revenue and Forecast, by Deployment Type
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product
12.3.5.2. Market Revenue and Forecast, by Service
12.3.5.3. Market Revenue and Forecast, by End Use Type
12.3.5.4. Market Revenue and Forecast, by Deployment Type
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product
12.3.6.2. Market Revenue and Forecast, by Service
12.3.6.3. Market Revenue and Forecast, by End Use Type
12.3.6.4. Market Revenue and Forecast, by Deployment Type
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product
12.3.7.2. Market Revenue and Forecast, by Service
12.3.7.3. Market Revenue and Forecast, by End Use Type
12.3.7.4. Market Revenue and Forecast, by Deployment Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product
12.3.8.2. Market Revenue and Forecast, by Service
12.3.8.3. Market Revenue and Forecast, by End Use Type
12.3.8.4. Market Revenue and Forecast, by Deployment Type
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product
12.4.2. Market Revenue and Forecast, by Service
12.4.3. Market Revenue and Forecast, by End Use Type
12.4.4. Market Revenue and Forecast, by Deployment Type
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product
12.4.5.2. Market Revenue and Forecast, by Service
12.4.5.3. Market Revenue and Forecast, by End Use Type
12.4.5.4. Market Revenue and Forecast, by Deployment Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product
12.4.6.2. Market Revenue and Forecast, by Service
12.4.6.3. Market Revenue and Forecast, by End Use Type
12.4.6.4. Market Revenue and Forecast, by Deployment Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product
12.4.7.2. Market Revenue and Forecast, by Service
12.4.7.3. Market Revenue and Forecast, by End Use Type
12.4.7.4. Market Revenue and Forecast, by Deployment Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product
12.4.8.2. Market Revenue and Forecast, by Service
12.4.8.3. Market Revenue and Forecast, by End Use Type
12.4.8.4. Market Revenue and Forecast, by Deployment Type
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product
12.5.2. Market Revenue and Forecast, by Service
12.5.3. Market Revenue and Forecast, by End Use Type
12.5.4. Market Revenue and Forecast, by Deployment Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product
12.5.5.2. Market Revenue and Forecast, by Service
12.5.5.3. Market Revenue and Forecast, by End Use Type
12.5.5.4. Market Revenue and Forecast, by Deployment Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product
12.5.6.2. Market Revenue and Forecast, by Service
12.5.6.3. Market Revenue and Forecast, by End Use Type
12.5.6.4. Market Revenue and Forecast, by Deployment Type
13.1. Allscripts Healthcare Solutions, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Koninklijke Philips N.V.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthineers
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. International Business Machines Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. General Electric Company
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. InTouch Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Athenahealth, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cisco Systems, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. UnitedHealth Group
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medtronic plc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client